Orbimed Advisors Llc

Affiliations

  • Large Shareholder, Director at Corvus Pharmaceuticals Inc. (CRVS), 2021-09-22
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2021-09-21
  • Director at Repare Therapeutics Inc. (RPTX), 2021-09-08
  • Large Shareholder, Director at Xtant Medical Holdings Inc. (XTNT), 2021-08-17
  • Large Shareholder, Director at Imara Inc. (IMRA), 2021-07-23
  • Large Shareholder, Director at Acutus Medical Inc. (AFIB), 2021-07-21
  • Large Shareholder at Springworks Therapeutics Inc. (SWTX), 2021-06-25
  • Director at Janux Therapeutics Inc. (JANX), 2021-06-16
  • Large Shareholder at Neuropace Inc (NPCE), 2021-04-26
  • Director at Synlogic Inc. (SYBX), 2021-04-22
  • Director at Ikena Oncology Inc. (IKNA), 2021-04-13
  • Large Shareholder, Director at Edgewise Therapeutics Inc. (EWTX), 2021-03-31
  • Director at Oric Pharmaceuticals Inc. (ORIC), 2021-03-31
  • Large Shareholder, Director at Decibel Therapeutics Inc. (DBTX), 2021-02-20
  • Large Shareholder, Director at Adicet Bio Inc. (ACET), 2021-02-19
  • Large Shareholder, Director at Gemini Therapeutics Inc. (GMTX), 2021-02-10
  • Large Shareholder, Director at Terns Pharmaceuticals Inc. (TERN), 2021-02-09
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Large Shareholder, Director at Prelude Therapeutics Inc (PRLD), 2021-01-12
  • Large Shareholder at Cti Biopharma Corp (CTIC), 2021-01-11
  • Large Shareholder, Director at Verona Pharma Plc (VRNA), 2021-01-06
  • Large Shareholder at Aerpio Pharmaceuticals Inc. (ARPO), 2020-12-10
  • at Kinnate Biopharma Inc. (KNTE), 2020-12-09
  • Large Shareholder, Director at Silverback Therapeutics Inc. (SBTX), 2020-12-09
  • Large Shareholder, Director at Galecto Inc. (GLTO), 2020-11-05
  • Large Shareholder, Director at Arcutis Biotherapeutics Inc. (ARQT), 2020-10-06
  • Large Shareholder, Director at Logicbio Therapeutics Inc. (LOGC), 2020-10-05
  • Large Shareholder at Graybug Vision Inc. (GRAY), 2020-09-29
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
  • Large Shareholder, Director at 89Bio Inc. (ETNB), 2020-09-23
  • Director at Inspire Medical Systems Inc. (INSP), 2020-08-19
  • Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-17
  • Director at Fusion Pharmaceuticals Inc. (FUSN), 2020-07-02
  • Large Shareholder, Director at Compass Therapeutics Inc. (NONE), 2020-06-24
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2020-05-26
  • Large Shareholder at Alector Inc. (ALEC), 2020-04-17
  • Director at Keros Therapeutics Inc. (KROS), 2020-04-13
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-04
  • Large Shareholder, Director at Sierra Oncology Inc. (SRRA), 2020-01-31
  • Large Shareholder, Director at Tricida Inc. (TCDA), 2019-12-12
  • Large Shareholder at Tela Bio Inc. (TELA), 2019-11-14
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2019-05-22
  • Large Shareholder, Director at Nextcure Inc. (NXTC), 2019-05-13
  • Director at Turning Point Therapeutics Inc. (TPTX), 2019-04-24
  • Large Shareholder at Avedro Inc (AVDR), 2019-02-20
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2018-12-13
  • Director at Si-Bone Inc. (SIBN), 2018-10-19
  • Large Shareholder at Guardant Health Inc. (GH), 2018-10-11
  • Large Shareholder at Arvinas Holding Company Llc (ARVN), 2018-09-26
  • Large Shareholder at Steadymed Ltd. (STDY), 2018-09-07
  • Large Shareholder at Viewray Inc. (VRAY), 2018-08-21
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-24
  • Large Shareholder at Crinetics Pharmaceuticals Inc. (CRNX), 2018-07-18
  • Large Shareholder, Director at Armo Biosciences Inc. (ARMO), 2018-06-22
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Other at Rhythm Pharmaceuticals Inc. (RYTM), 2018-05-24
  • Large Shareholder, Other at Pieris Pharmaceuticals Inc. (PIRS), 2018-05-02
  • Large Shareholder at Audentes Therapeutics Inc. (BOLD), 2018-03-12
  • Director at Glaukos Corp (GKOS), 2018-03-07
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2018-02-12
  • Director at Loxo Oncology Inc. (LOXO), 2017-12-12
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Roka Bioscience Inc. (ROKA), 2017-10-05
  • Large Shareholder at Aeglea Biotherapeutics Inc. (AGLE), 2017-02-21
  • Large Shareholder, Director at Nabriva Therapeutics Ag (NBRV), 2016-12-30
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Large Shareholder at Relypsa Inc (RLYP), 2016-07-26
  • Large Shareholder, Director at Selecta Biosciences Inc (SELB), 2016-06-30
  • Director at Intellia Therapeutics Inc. (NTLA), 2016-05-13
  • Director at Otonomy Inc. (OTIC), 2015-11-30
  • Large Shareholder, Director at Dimension Therapeutics Inc. (DMTX), 2015-10-29
  • Large Shareholder at Sientra Inc. (SIEN), 2015-10-13
  • Director at Intercept Pharmaceuticals Inc (ICPT), 2015-07-22
  • Large Shareholder at Mirati Therapeutics Inc. (MRTX), 2015-02-05
  • Other at Acceleron Pharma Inc (XLRN), 2013-09-26
  • Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-05-24
  • Large Shareholder at Supernus Pharmaceuticals Inc (SUPN), 2013-02-14
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2013-02-02
  • Director at Amarin Corp Plc (AMRN), 2012-09-05
  • Large Shareholder at Complete Genomics Inc (GNOM), 2012-07-13
  • Large Shareholder at Pacira Pharmaceuticals Inc. (PCRX), 2012-03-13
  • Large Shareholder at Chemocentryx Inc. (CCXI), 2012-02-16
  • Large Shareholder at Athersys Inc / New (ATHX), 2011-04-30
  • Director at Nxstage Medical Inc. (NXTM), 2010-12-13
  • Large Shareholder at Kun Run Biotechnology Inc. (KURU.OB), 2010-05-10
  • Director at Biodel Inc (BIOD), 2009-06-11
  • Large Shareholder at Aryx Therapeutics Inc. (ARYX), 2009-05-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $9.40 425,531 Large Shareholder, Director 425,531 2021-09-17 Filing
ALPN $9.40 585,106 Large Shareholder, Director 3,656,061 2021-09-17 Filing
IMRA $6.00 1,666,666 Large Shareholder, Director 4,199,068 2021-07-16 Filing
AFIB $14.00 357,143 Large Shareholder, Director 1,677,361 2021-07-19 Filing
AFIB $14.00 714,285 Large Shareholder, Director 4,872,025 2021-07-19 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CRVS $6.09 1,109,644 Large Shareholder, Director 6,943,654 2021-09-20 Filing
RPTX $33.93 26 Director 96,190 2021-09-07 Filing
RPTX $33.93 861 Director 3,177,041 2021-09-07 Filing
RPTX $34.00 212 Director 96,216 2021-09-03 Filing
RPTX $34.00 6,985 Director 3,177,902 2021-09-03 Filing